MAI Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156K | Buy |
3,209
+144
| +5% | +$7K | ﹤0.01% | 1234 |
|
|
2025
Q1 | $104K | Sell |
3,065
-1,518
| -33% | -$51.7K | ﹤0.01% | 1323 |
|
|
2024
Q4 | $180K | Hold |
4,583
| – | – | ﹤0.01% | 1121 |
|
|
2024
Q3 | $215K | Sell |
4,583
-870
| -16% | -$40.9K | ﹤0.01% | 954 |
|
|
2024
Q2 | $295K | Sell |
5,453
-331
| -6% | -$17.9K | ﹤0.01% | 970 |
|
|
2024
Q1 | $394K | Buy |
5,784
+506
| +10% | +$34.5K | ﹤0.01% | 859 |
|
|
2023
Q4 | $330K | Buy |
5,278
+720
| +16% | +$45.1K | ﹤0.01% | 816 |
|
|
2023
Q3 | $207K | Buy |
4,558
+431
| +10% | +$19.6K | ﹤0.01% | 930 |
|
|
2023
Q2 | $232K | Buy |
+4,127
| New | +$232K | ﹤0.01% | 894 |
|
|
2022
Q4 | – | Sell |
-4,157
| Closed | -$272K | – | 1002 |
|
|
2022
Q3 | $272K | Buy |
4,157
+502
| +14% | +$32.8K | 0.01% | 709 |
|
|
2022
Q2 | $222K | Buy |
+3,655
| New | +$222K | ﹤0.01% | 742 |
|